tbuckley/cabot-search huggingface dataset:
Preliminary Efficacy and Safety of the CK1ε/PI3Kδ Dual Inhibitor HZ-H08905 in Patients with Relapsed and/or Refractory B-Cell Lymphomas: Results from the Phase 1 HZ-H08905-101 Study
Authors: Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Bo Zhang, Miao Hu, Yanping Zhang, Xinglu Zhou, Jie Jin
Journal: Blood (2024)
Distinct Signaling Profiles in Primary Splenic Small B-Cell Lymphomas
Authors: Marina Gerousi, Maria Fitopoulou, Malama Galanou, Philip Rock, Georgios Karakatsoulis, Anastasia Anastasiadou, Maria Karipidou, Anastasia Iatrou, Efthalia Karamanli, Nikolaos Vastarouchas, Paolo Ghia, Charles C Chu, Clive S Zent, Richard Burack, Anastasia Chatzidimitriou, Kostas Stamatopoulos
Journal: Blood (2024)
Extended Vs Standard Hypomethylating Agent Dosing in Combination with Venetoclax in Newly Diagnosed Acute Myeloid Leukemia
Authors: Georgio Medawar, Serena Tharakan, Dahniel L Sastow, Vincent Lok, Su Bin Hahn, Preston Perez, Abigail Demers, David M Swoboda, Douglas Tremblay, Alexander Coltoff
Journal: Blood (2024)
CD7.Pebl-CART for Patients with Relapsed/Refractory (r/r) T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Authors: Marco Becilli, Francesca Del Bufalo, Pietro Merli, Daria Pagliara, Chiara Rosignoli, Valentina Bertaina, Giuseppina Li Pira, Maria Giuseppina Cefalo, Monica Gunetti, Stefano Iacovelli, Emilia Boccieri, Matilde Sinibaldi, Yunqin Lee, Concetta Quintarelli, Dario Campana, Franco Locatelli
Journal: Blood (2024)
Efficacy of Carvykti in Cartitude-4 Versus Other Conventional Treatment Regimens for Lenalidomide-Refractory Multiple Myeloma Patients Using Inverse Probability of Treatment Weighting
Authors: Rafael Fonseca, Joris Diels, Francesca Ghilotti, João Mendes, Teresa Hernando, Seina Lee, Jordan M. Schecter, Nikoletta Lendvai, Nitin Patel, Ana Triguero, Winfried Alsdorf, Margherita Ursi
Journal: Blood (2024)
Teclistamab in Relapsed and Refractory Multiple Myeloma Patients - Czech Multi-Center Real World Evidence Analysis
Authors: Martin Stork, Jakub Radocha, Tomas Jelinek, Ivan Spicka, Tomas Pika, Alexandra Jungova, Jan Straub, Jiri Minarik, Ivanna Boichuk, Dominik Fric, Denisa Novakova, Tereza Popkova, Lenka Polcerova, Vladimir Maisnar, Ludek Pour, Roman Hajek
Journal: Blood (2024)
Mitapivat-Induced Improvements in RBC Deformability and Membrane Integrity in Patients with Sickle Cell Disease Are Sustained during Extended Therapy
Authors: Xunde Wang, Yechan Cho, Nancy Asomaning, Maureen Lundt, Anna Conrey, Britney Kruah, Amber M Yates, Megan Wind-Rotolo, Haiou Li, Kang Le, Swee Lay Thein
Journal: Blood (2024)
Brigatinib Monotherapy in Children with R/R ALK+ ALCL, IMT, or Other Solid Tumors: Updated Results from the Brigaped (ITCC-098) Phase 1 Dose-Escalation Study
Authors: Charlotte Rigaud, Kim P.J. Schellekens, Christine Damm-Welk, Veronique Minard-Colin, Samuel D. Abbou, Gertruud Bakker, Auke Beishuizen, Maaike Boonstra-Schelfhorst, Laurence Brugières, Michela Casanova, Pascal Chastagner, Rana Dandis, Stéphane Ducassou, Natasha K.A. van Eijkelenburg, Nathalie Garnier, Michael J. Hanley, Alwin D.R. Huitema, Samantha Lampron, Yousif H. Matloub, Nicole Scobie, Florin Vranceanu, Jen-Hao Wu, Wilhelm Woessmann, C. Michel Zwaan, Reineke A. Schoot
Journal: Blood (2024)
Evaluation of the Safety and Efficacy of Denosumab in Patients with Multiple Myeloma and Severe Renal Impairment; Results from an IMWG Bone Subcommittee Study
Authors: Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Charalampia Kyriakou, Carlyn Rose Tan, Niels Abildgaard, Michel Delforge, Dorotea Beatriz Eugenia Fantl, Cristian M Seehaus, Emilie Carneiro, Cristina João, Saad Z. Usmani
Journal: Blood (2024)
Healthcare Resource Utilization and Costs Associated with Managing CRS and ICANS in Patients with Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia Receiving Obecabtagene autoleucel (obe-cel)
Authors: Bijal D Shah, Jeremy Pantin, Karamjeet S Sandhu, Elias Jabbour, Jae H. Park, Paul Shaughnessy, Mehrdad Abedi, Michael R Bishop, Daniel J. DeAngelo, Wolfram Brugger, Martin Brown, Dilip Patel, Claire Roddie, Aaron C. Logan
Journal: Blood (2024)
DeepSurf2-FF: Introducing Force Fields in Deep Learning for Improving in-Silico Prediction of Bcr-Antigen Interactions in B Cell Lymphomas
Authors: Angelos-Michael Papadopoulos, Anastasia Iatrou, Apostolos Axenopoulos, Paolo Ghia, Kostas Stamatopoulos, Federico Alvarez, Petros Daras
Journal: Blood (2024)
Transcriptome-Based Molecular Subtypes Improve the Classification of B Cell Acute Lymphoblastic Leukemia with JAK2 Translocation
Authors: Bingqing Huang, Yujiao Jia, Haoxu Wang, Huijun Wang, Qi Sun, Chengwen Li, Hui Wei, Yingchang Mi, Xiaofan Zhu, Jianxiang Wang, Zhijian Xiao
Journal: Blood (2024)
Improvement in Quality of Life in MDS Patients Who Become Transfusion Independent after Treatment
Authors: Bo Wan, Shabbir MH Alibhai, Lisa Chodirker, Lee Mozessohn, Michelle Geddes, Nancy Zhu, Amy Trottier, Eve St-Hilaire, Nicholas Finn, Brian Leber, Dina Khalaf, Grace Christou, Mitchell Sabloff, Heather A Leitch, April Shamy, Karen Yee, John M. Storring, Thomas J. Nevill, Brett L. Houston, Mohamed Elemary, Robert Delage, Anne Parmentier, Mohammad Siddiqui, Alexandre Mamedov, Liying Zhang, Rena Buckstein
Journal: Blood (2024)
CD19 CAR T Cells Drive a Remodeling of the Immune Microenvironment Associated with T-Cell Dysfunction in Acute Lymphoblastic Leukemia
Authors: Marianna Ponzo, Lorenzo Drufuca, Chiara Buracchi, Marco M Sindoni, Silvia Nucera, Cristina Bugarin, Ramona Bason, Grazisa Rossetti, Raul Bonnal, Cristian Meli, Benedetta Rambaldi, Federico Lussana, Silvia Ferrari, Alex Moretti, Giulia Risca, Christian Pellegrino, Markus G. Manz, Stefania Galimberti, Alessandro Rambaldi, Andrea Biondi, Giuseppe Gaipa, Massimiliano Pagani, Chiara F. Magnani
Journal: Blood (2024)
Survival of Multiple Myeloma Patients in Epic Cosmos Confounded By Death Reporting
Authors: Craig C. Hofmeister, Mingyuan Zhang, Vikas A. Gupta, Nisha S. Joseph, Jonathan L. Kaufman, Ajay K. Nooka, Madhav V. Dhodapkar, Sagar Lonial, Douglas W. Sborov
Journal: Blood (2024)
Evaluating Efficacy and Safety of Rapid-Manufactured CD5KO CART5 Cells in Preclinical Models of T Cell Malignancies
Authors: Ruchi P. Patel, Trang Vu, Dean Qian, Yunlin Zhang, Guido Ghilardi, Steven Yang, Stefan K. Barta, Nicholas A. Siciliano, Adam E. Snook, Marco Ruella
Journal: Blood (2024)
Long-Term Follow-up of Real-World Teclistamab Therapy for Relapsed/Refractory Multiple Myeloma from the IMWG Immunotherapy Working Group Committee
Authors: Carlyn Rose Tan, Sireesha Asoori, David Nemirovsky, Andriy Derkach, Larissa Brunaldi, Rakesh Popat, Chris Lau, Efstathios Kastritis, Joaquín Martínez-Lopez, Radhika Bansal, Andre De Menezes Silva Corraes, Saurabh Chhabra, Ricardo D. Parrondo, Sikander Ailawadhi, Despina Fotiou, Meletios Dimopoulos, Kwee Yong, Catriona Mactier, Magdalena Corona, Adolfo Jesús Sáez Marín, Hira Mian, Saad Z. Usmani, Brian G.M. Durie, Thomas G Martin, Yi Lin
Journal: Blood (2024)
CD39, CD73 and the Adenosine Pathway Mediate Immune Escape in Juvenile Myelomonocytic Leukemia (JMML)
Authors: Jovana Rajak, Ke Meng, Anna Lena Stippel, Jun Wang, Naile Koleci, Alexandra Emilia Schlaak, Hui Xiao, Christian Flotho, Charlotte Marie Niemeyer, Bertram Bengsch, Miriam Erlacher
Journal: Blood (2024)
Gemtuzumab Based Induction Chemotherapy Combined with Midostaurin for FLT3 Mutated Patients. Results from the Patient- Reported Outcome Measures from the NCRI AML19V2 ‘Midotarg Pilot‘
Authors: Joanna Canham, Ian Thomas, Nigel H. Russell, Jane Leahy, Abin Thomas, Steve Knapper, Lucy Marsh, Huda Mohamed, Sean Johnson
Journal: Blood (2024)
Real-World Patterns of Care and Outcomes for Non-Favourable Risk Acute Myeloid Leukemia Treated with Intensive Chemotherapy across Australia and New Zealand- Data Linkage between the ALLG National Blood Cancer Registry (NBCR) and the Australia and New Zealand Transplant and Cellular Therapy (ANZTCT) Registry
Authors: Nisha Thiagarajah, Mark R Dowling, Karin Dunne, Donna Aarons, Jenny Collins, Steven Tran, Shaun Fleming, Gaurav Sutrave, Devendra Hiwase, Chun Yew Fong, Blake Hsu, Duncan Purtill, Anne-Marie Watson, Glen A Kennedy, William S Stevenson, Stephen Robert Larsen, John Moore, Travis Perera, David S. Ritchie, Andrew Wei, Andrew W. Roberts, Nada Hamad, Ashish Bajel
Journal: Blood (2024)
The Bispecific Innate Cell Engager AFM28 Can Leverage AML Patient's NK Cells in Addition to Allogeneic NK Cells, Enabling Elimination of CD123+ Leukemic Stem and Progenitor Cells in AML and MDS
Authors: Nanni Schmitt, Jana-Julia Siegler, Alexandra Beck, Lea Hoppe, Mohammed Abba, Alexander Streuer, Stefan Klein, Wolf-Karsten Hofmann, Christian Merz, Jens Pahl, Daniel Nowak
Journal: Blood (2024)
CTX112, a Next-Generation Allogeneic CRISPR-Cas9 Engineered CD19 CAR T Cell with Novel Potency Edits: Data from Phase 1 Dose Escalation Study in Patients with Relapsed or Refractory B-Cell Malignancies
Authors: Armin Ghobadi, Joseph P. McGuirk, Paul Shaughnessy, Constantine S. Tam, Melanie Allen, Chenyi Pan, Ziliang Li, William N. Stevens, Annie Weaver, Chan Y. Cheah
Journal: Blood (2024)
Multiple Lines of Therapy and Progression to Next Lines in Multiple Myeloma Patients: Real-World Studies in Argentina (TOTEMM-A) and Brazil (TOTEMM-B)
Authors: Gabriela A Abreu, Juliana Queiroz, Thiago Luiz Nogueira da Silva, Claudia R Soares, Patricia Menezes, Mariano Carrizo, Tatiana Ricca, Tatiana Pires, Straus Tanaka, Lucas Perelli, Graziela Bernardino, André Luiz Alves Ribeiro de Souza, Ventura Simonovich, Paula Scibona, Cristian M Seehaus, Erika B Brulc, Natalia Kim, Laura Jotimliansky
Journal: Blood (2024)
Early Versus Delayed Intervention in Smoldering Multiple Myeloma: A Meta-Analysis of Clinical Trials
Authors: Greeshma Gaddipati, Boniface Mensah, Chiranjeevi Sainatham, Greeshma Erasani, Mariah Malak Bilalaga, Ramya Vasireddy, Shree Rath, Joseph Atarere, Sujitha Ketineni, Mahsa Mohebtash
Journal: Blood (2024)
A Multicenter Clinical Study of Cccg - APL-2017 in the Treatment of Children with Acute Promyelocytic Leukemia
Authors: Lixian Chang, Ju GAO, Xiaoying Lei, Yingyi He, Shuquan Zhuang, Chunhuai Li, Kaizhi Weng, Lingzhen Wang, Xia Guo, Qihui Liu, Pengfei Wang, Yong Zhuang, Mei Yan, Wei Liu, Hui Chen, Min Zhang, Shuhong Shen, Xiaofan Zhu, Xiuli Ju, Li Zhang, Zhuo Wang
Journal: Blood (2024)
Meaningful Change in Patient-Reported Outcomes after CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma in Standard of Care: Differences By Race and Ethnicity
Authors: Carina E. Ferraris, Xiaoyin Li, Gabriel De Avila, Lisa M. Gudenkauf, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, Sylvia L. Crowder, Nathan Parker, Tiffany L. Carson, Rachid C. Baz, Kenneth H. Shain, Brandon Blue, Ariel Grajales-Cruz, Melissa Alsina, Ciara Louise Freeman, Omar Castaneda, Taiga Nishihori, Hien Liu, Frederick L. Locke, Heather S.L. Jim, Doris K. Hansen, Lauren C. Peres, Laura B. Oswald
Journal: Blood (2024)
Clinical Outcomes and Variability Based on Baseline Cytogenetic Risk of Patients with MDS Treated with Hypomethylating Agents: An Analysis from the International Consortium for MDS (icMDS) Validate Database
Authors: Ted M. Getz, Tariq Kewan, Jan Philipp Bewersdorf, Jessica M. Stempel, Luca Lanino, Wei Wei, Najla H. Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L. Uy, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine M. McMahon, Rory M. Shallis, Joshua F Zeidner, Michael R. Savona, Somedeb Ball, Namrata S. Chandhok, Constantine Logothetis, Aram Bidikian, Gail J. Roboz, Benjamin Rolles, Eunice S. Wang, Amyah C. Harris, Maria L Amaya, Hayley Hawkins, Justin Grenet, Zhuoer Xie, Yazan F. Madanat, Yasmin Abaza, Talha Badar, Torsten Haferlach, Jaroslaw Maciejewski, David Sallman, Anoop K Enjeti, Kamal Al-Rabi, Khalid Halahleh, Devendra Hiwase, Maria Diez-Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vasiliki Pappa, Valeria Santini, Angela Consagra, Aref Al-Kali, Seishi Ogawa, Yasuhito Nannya, Maximilian Stahl, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan
Journal: Blood (2024)
Long Term Follow-up Data after Consolidation Therapy with Ponatinib in Combination with Cytarabine in Patients with FLT3 Mutated Acute Myeloid Leukemia in First Complete Remission
Authors: Thibaut Leguay, Laurène Fenwarth, Thomas Cluzeau, Anne Vekoff, Etienne Lengline, Juliette Lambert, Denis Caillot, Mathilde Hunault, Jean-Valère Malfuson, Sylvain Chantepie, Emmanuelle Tavernier, Berengere Gruson, José Fernandes, Pierre Peterlin, Melody Fort, Laure Morisset, Herve Dombret, Claude Preudhomme, Arnaud Pigneux, Philippe Rousselot
Journal: Blood (2024)
Validation of the CNS-IPI-C Prognostic Model in Patients with Systemic DLBCL in the Real World
Authors: Michal Masar, Prokop Vodicka, Samuel Hricko, Andrea Janikova, Katerina Benesova, David Salek, Jana Salkova, Martina Filipova, Jan Galko, Vit Campr, Magdalena Klanova, Marek Trneny
Journal: Blood (2024)
Safety and Efficacy of CD22/ CD19 CAR-T and Auto-HSCT “Sandwich”Strategy As Consolidation Therapy for Ph Negative B Cell Acute Lymphoblastic Leukemia
Authors: Zihao Wang, Chong-Sheng Qian, Yan Qiu, Hai-xia Zhou, Mingzhu Xu, Li-Qing Kang, Ai-Ning Sun, Depei Wu, Lei Yu, Sheng-Li Xue
Journal: Blood (2024)
Clinical Characteristics and Outcomes of Patients with MYD88 Positive Waldenström Macroglobulinemia: A Single Center Retrospective Analysis
Authors: Shrinjaya B Thapa, David Kaldas, Jose Laborde, Shrikar Modukuri, Filip Ionescu, Brandon Blue, Julio C. Chavez, Melissa Alsina, Celeste M. Bello, Javier Pinilla-Ibarz, Kenneth H. Shain, Rachid C. Baz, Ariel Grajales-Cruz
Journal: Blood (2024)
Real-World Experience with CPX-351 for Secondary Acute Myeloid Leukemia: Comparison with FLAG-IDA in a Propensity Score Matching Analysis
Authors: Maria Agustina Perusini, Claire Andrews, Eshetu G Atenafu, Sarit E. Assouline, Joseph Brandwein, Mohammad Jarrar, Steven M. Chan, Signy Chow, Dina Khalaf, Vikas Gupta, Dawn C. Maze, Mark D. Minden, Gizelle Popradi, Waleed Sabry, Lalit Saini, David Sanford, Lynn Savoie, Aaron Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai
Journal: Blood (2024)
Bird Regimen Followed By Anti-BCMA CAR T-Cell Immunotherapy As First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 3 Trial
Authors: Yue Zhou, Juan Chen, Qingya Cui, Haiping Dai, Zheng Li, Jia Yin, Wei Cui, Mengyun Li, Xuekai Li, Xin Zhang, Feiran Gong, Xiaming Zhu, Liqing Kang, Lei Yu, Depei Wu, Xiaowen Tang
Journal: Blood (2024)
Idecabtagene Vicleucel (ide-cel) Shows Similar Efficacy and Toxicity in Patients with Multiple Myeloma Aged 70 and Older Compared to Younger Patients: A Multicenter Cohort Study
Authors: Philipp Berning, Markus Maulhardt, Hristo Boyadzhiev, Anca Maria Albici, Snjezana Janjetovic, Anna Ossami Saidy, Christian R Schultze-Florey, Simon Call, Natalie Schub, Annamaria Brioli, Michael Daskalakis, Juliane Knust, Justin Hasenkamp, Matthias Stelljes, Cyrus Khandanpour, Ulrike Bacher, Christine Hanoun, Florian Heidel, Hans Christian Reinhardt, Georg Lenz, Gerald Wulf, Friedrich Stölzel, Bastian von Tresckow, Thomas Pabst, Evgenii Shumilov
Journal: Blood (2024)
Updated Results of a Phase I Study of Uproleselan Combined with Azacitidine and Venetoclax for the Treatment of Older or Unfit Patients with Treatment Naïve Acute Myeloid Leukemia
Authors: Brian A. Jonas, Zarir E. Karanjawala, Laura Molnar, Ashley Linh Dang-Chu, Mehrdad Abedi, Naseem S. Esteghamat, Aaron S. Rosenberg, Francisco Andres Socola, Lihong Qi, Joseph M. Tuscano
Journal: Blood (2024)
UM171 Cord Blood Transplantation for TP53 Mutated and EVI1 Rearranged Myelodysplasia/Acute Myeloid Leukemia
Authors: Sandra Cohen, Nadia M. Bambace, Lea Bernard, Imran Ahmad, Jean Roy, Sylvie Lachance, Jean-Sebastien Delisle, Thomas L. Kiss, Denis-Claude Roy, Olivier Veilleux, Guy Sauvageau
Journal: Blood (2024)
Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Individuals with the Duffy Null Phenotype or Genotype
Authors: Stephen P Hibbs, Israel Chipare, Amr J Halawani, Sophie E Legge, Geoffrey Fell, Abdulrahman A. Alhamzi, Edwig Shingenge, Mohammed J Alabdly, Hilary T Charuma, Mohammed A Nushaily, Judith M Sinvula, Menelik Russo, Sara Paparini, Nancy Berliner, Vanessa Apea, Maureen Achebe, Lauren E. Merz
Journal: Blood (2024)
HLA-DR Expression on Leukemic Progenitor Cells before Allogeneic Hematopoietic Cell Transplantation Adds Prognostic Value in the Presence of MRD
Authors: Maximilian Alexander Rohnert, Jonas Schadt, Michael Kramer, Christoph Röllig, Johannes Schetelig, Friedrich Stölzel, Désirée Kunadt, Jan Moritz Middeke, Lars Thielecke, Friedemann Uschner, Ingmar Glauche, Christian Thiede, Martin Bornhaeuser, Uta Oelschlaegel, Malte von Bonin, Uwe Platzbecker, Claudia D Baldus, Hubert Serve, Carsten Mueller-Tidow
Journal: Blood (2024)
<i>In-</i>class Transition from Parenteral Bortezomib to Oral Ixazomib in Newly Diagnosed Multiple Myeloma: Analysis of US MM-6 By Number of Treatment Cycles Received
Authors: Joshua Richter, Saulius Girnius, Ruemu Birhiray, Eric Lloyd, Dasha Cherepanov, Stephen J. Noga, Isabel Nascimento-Ferreira, Robert Rifkin
Journal: Blood (2024)
Efficacy and Molecular Predictors of Response and Survival for Venetoclax/Azacitidine Therapy in Relapsed or Refractory Acute Myeloid Leukemia
Authors: Jason S. Gilbert, Megan Connor, Grace Bosma, Christine M. McMahon, Maria L Amaya, Jonathan Gutman, Marc Schwartz, Andrew Kent, Diana Abbott, Daniel A Pollyea
Journal: Blood (2024)
Effect of Rituximab on Spleen and Blood B-Cell Subpopulations in Allo-Immunized Children with Sickle Cell Anemia
Authors: Jérémy Morel, Charline Oddon, Lea Kuznicki, Laetitia Claer, Berengere Koehl, Jean-Hugues Dalle, Laurent Holvoet, Florence Missud, Malika Benkerrou, Ghislaine Ithier, Arnaud Bonnard, Liza Ali, Slim Azouzi, Sandrine Laurance, Valentine Brousse
Journal: Blood (2024)
Predictors of Liver Response in Light Chain (AL) Amyloidosis: A Study with 130 Patients
Authors: Nadia Toumeh, Matthew James Rees, Morie A. Gertz, Angela Dispenzieri, Binoy Yohannan, Suheil Albert Atallah-Yunes, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, Suzanne R Hayman, Francis Buadi, David Dingli, Joselle Cook, Rahma M Warsame, Moritz Binder, Wilson I. Gonsalves, S. Vincent Rajkumar, Shaji Kumar, Eli Muchtar
Journal: Blood (2024)
Prospective Patient Preference Study for Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Attributes and Factors Affecting Patient Shared Decision-Making in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) in the United States (USA)
Authors: Sikander Ailawadhi, Swetha Challagulla, Dominic Pilon, Yan Meng, Mei Xue, Yuxi Wang, Keri Yang
Journal: Blood (2024)
Immunological Predictive Markers of Response to Idecabtagene Vicleucel Therapy in Multiple Myeloma : A Real-World Experience from St Louis Hospital (France)
Authors: Benoit Ferment, Amani Ouedrani, Romain Stammler, William Dartois, Stephanie Harel, Bruno Royer, Nathalie Forgeard, Tristan Vaugeois, Alexis Talbot, Jean-Christophe Bories, Bertrand Arnulf, Sophie Caillat-Zucman
Journal: Blood (2024)
Improvement in Cerebral Vasoreactivity after 6 Months of Voxelotor Measured By Near-Infrared Spectroscopy (NIRS) in Sickle Cell Disease Patients
Authors: Gonzalo De Luna, Suella Martino, Philippe Le Corvoiser, Christophe Ferreira De Matos, Sihem Alouni, Dalila Bitari, Etienne Audureau, Fatima Bensiradj, Thomas Rupp, Anoosha Habibi, Jamila Alhamrouni, PA Natella, David Calvet, Pablo Bartolucci
Journal: Blood (2024)
Impact of CAR T-Cell Persistence on Clinical Outcomes in Relapsed/Refractory Multiple Myeloma: Insights from the Phase 2 Fumanba-1 Study
Authors: Chunrui Li, Dehui Zou, Di Wang, Baijun Fang, He Huang, Jianyong Li, Bing Chen, Jing Liu, Xi Zhang, Yujun Dong, Kai Hu, Peng Liu, Jianqing Mi, Kaiyang Ding, Zhenyu Li, Qie Dong, Fuyuan Zhang, Guang Hu, Lu-Gui Qiu
Journal: Blood (2024)
Evaluation of Sleep Apnea in Adult Sickle Cell Disease; About 107 SS and Sβ°Thal Patients
Authors: Anoosha Habibi, ALA Covali, Emilie Bequignon, Vincent Malcor Deydier De Pierrefeu, Laurent Boyer, Vincent Latournerie, Bernard Maitre, Gonzalo De Luna, Thomas D'Humieres, Pablo Bartolucci, Serge Adnot
Journal: Blood (2024)
Prognostic Value of Positron Emission Tomography/Computed Tomography in Multiple Myeloma Patients Treated with Ide-Cel CAR-T Cell Therapy: Preliminary Results of a Real-World IFM Study from the Descar-T Registry (CAR MY PET)
Authors: Bertrand Arnulf, Laetitia Vercellino, Denis Caillot, Jérôme Lambert, Bastien Jamet, Aurore Perrot, Pierre Bories, Olivier Decaux, Lionel Karlin, Anne Lazareth, Laure Vincent, Christine Latry Kuhn, Cyrille Touzeau, Harel Stephanie, Mohamad Mohty, Florent Malard, Salomon Manier, Ibrahim Yakoub-Agha, Alexis Talbot, Niels Moya, Arthur Bobin, Marie-Odile Petillon, Noemie Bigot, Thierry Facon, Jill Corre, Herve Avet-Loiseau, Philippe Moreau, Françoise Kraeber-Bodéré
Journal: Blood (2024)
Zilovertamab Vedotin Monotherapy for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort a of the Multicenter, Open-Label, Phase 2 Waveline-006 Study
Authors: Ingrid Glimelius, Won Seog Kim, Ewa Paszkiewicz-Kozik, Daniel Ernst, Reid W. Merryman, Claudia Moreira, Sanfang Tu, Yixin Ren, Katherine Ryland, Uzor C. Ogbu, Pier Luigi Zinzani
Journal: Blood (2024)
5-Year Follow-up of Combined Infusion of Anti-CD19 and Anti-BCMA CAR-T after ASCT for High-Risk Newly Diagnosed Multiple Myeloma
Authors: Xiaolan Shi, Chengcheng Fu, Lingzhi Yan, Yingying Zhai, Zhi Yan, Jingjing Shang, Song Jin, Xingyue Wu, Hongying You, Shuang Yan, Weiqin Yao, Liqing Kang, Lei Yu, Depei Wu
Journal: Blood (2024)
Clinical and Laboratory Characteristics of Pediatric Patients with <i>ACKR1/Darc</i>-Associated Neutropenia
Authors: Lital Oz-Alcalay, Orna Steinberg-Shemer, Sarah Elitzur, Dafna Brik Simon, Hannah Tamary, Shai Izraeli, Joanne Yacobovich, Oded Gilad
Journal: Blood (2024)
Circulating Tumor DNA Kinetics at Day 14 after CAR T-Cell Therapy Identifies Patients with B-Cell Lymphoma at Risk for Early Treatment Failure
Authors: Tim Versteegen, Philipp Nakov, Nikos Darzentas, Guranda Chitadze, Ingram Iaccarino, Wolfram Klapper, Natalie Schub, Monika Brüggemann, Friedrich Stoelzel, Claudia D Baldus, Christiane Pott, Mouhamad Khouja
Journal: Blood (2024)
OEF Measured with Diffuse Optical Spectroscopies As a Biomarker of Silent Stroke in Pediatric Sickle Cell Anemia
Authors: Rowan Brothers, Michael Arrington, Kristin Wubbena, Ayesha Quadri, Mariam Akbar, Katherine Turrentine, Eswar Damaraju, Richard Jones, Jack Knight-Scott, Bryan Philbrook, Clark Brown, Beatrice E Gee, Kirshma Khemani, Seung Yup Lee, Adam Goldman-Yassen, Erin Buckley
Journal: Blood (2024)
Encouraging Efficacy of Bexmarilimab with Azacitidine in Relapsed or Refractory MDS in Bexmab Ph1/2 Study
Authors: Mika Kontro, Anthony S. Stein, Marja Pyörälä, Johanna Rimpiläinen, Timo Siitonen, Jenna H Rannikko, Jesper Mickos, Rita Turpin, Milja Hakoniemi, Birge Berns, Sofia Aakko, Inka Pawlitzky, Maija Hollmén, Amer M. Zeidan, Naval Daver
Journal: Blood (2024)
RNA Methyltransferase Mettl16 Is Indispensable for the Survival of Naïve CD4+ T Cells In Vivo
Authors: Daigo Michimata, Hiroki Kato, Naoya Morota, Yuya Tanaka, Kazuki Sakurai, Kazuki Hashimoto, Koichi Onodera, Shunsuke Hatta, Yasushi Onishi, Noriko Fukuhara, Hideo Harigae
Journal: Blood (2024)
Illuminating the Functional Architecture of iPSC-Derived Neutrophil Granulocytes with Split Fluorescent Proteins
Authors: Daniel Petersheim, Monika I Linder, Mehmet T Kiziltug, Johanna Schmid, Almke Bader, Daniela Maier-Begandt, Barbara Walzog, Jörg Renkawitz, Christoph Klein
Journal: Blood (2024)
End-of-Life Care Patterns in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Real-World Setting
Authors: Paul A. Hamlin, Pallawi Torka, Eric Hansen, Andrew J. Belli, Jacob Ambrose, Christina M. Zettler, Laura L. Fernandes, Stephanie Wiley, Brittney Perry, Ching-Kun Wang
Journal: Blood (2024)